Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Enhabit, Inc.
EHAB
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $706.9M
$13.80
▲ +0.07%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$6.47 - $14.22
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 41.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Large multi-state network of 351 agencies providing scale and operational efficiency
- Comprehensive service integration enabling coordinated patient care across home health and hospice
- Established relationships with hospitals, physicians, and payers across 34 states
- Specialized expertise in complex wound care, infusion therapy, and chronic disease management
Bear Case
2 risks
- Average volatility.
- Premium valuation to Healthcare Facilities peers
Growth
Turning profitable
Aging U.S. population increasing demand for home-based healthcare services
Value
Premium valuation to Healthcare Facilities peers
Momentum
Stable
+1.3% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying EHAB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 5, 2026
MAY 20, 2026
Reported EPS of $0.13 vs $0.12 consensus (+11.0% surprise). Revenue of $264.8M vs $266.7M expected (-0.7%).
EPS surprise · last 4Q
4 of 4 beats
Q2 26
+11.0%
Q2 26
+11.0%
Q2 26
+208.3%
Q2 26
+208.3%
Next: May 5, 2026
Revenue trend · last 8Q
—
—
-1%
-1%
+2%
+4%
+5%
+2%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$260.6M
$253.6M
$258.2M
$259.9M
$266.1M
$263.6M
$270.4M
$264.8M
Margins · last 8Q
Gross
—
Operating
—
Profit
7.3%
Wall Street consensus
4 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: TD Cowen · Mar 6, 2026